In Clinic Evaluation of the PLGM Feature

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Type 1 Diabetes
Interventions
DEVICE

Predictive Low Glucose Management Feature in Insulin pump

All subjects will undergo hypoglycemic induction at Visit 2 with target set to 65 mg/dL using the rate of change basal increase algorithm. Low Limit setting when PLGM ON is 65 mg/dL.

Trial Locations (8)

22903

University of Virgina, Charlottesville

30318

Atlanta Diabetes Associates, Atlanta

80045

Barbara Davis Center of Childhood Diabetes, Denver

92026

AMCR Institute, Inc., Escondido

94305

Stanford University Department of Pediatric Endocrinology, Stanford

94598

Diablo Clinical Research, Walnut Creek

98057

Rainier Clinical Research, Renton

06519

Yale University Diabetes Research Program, New Haven

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT02130284 - In Clinic Evaluation of the PLGM Feature | Biotech Hunter | Biotech Hunter